These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3899653)

  • 1. Effect of i.v. and oral tiapamil in the treatment of paroxysmal supraventricular tachycardia.
    Fauchier JP; Elkik F; Cosnay P; Rouesnel P; Neel C; Quillet L
    Eur Heart J; 1985 Jun; 6(6):525-31. PubMed ID: 3899653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tiapamil in the Wolff-Parkinson-White syndrome.
    Gmeiner R; Ng CK
    J Cardiovasc Pharmacol; 1981; 3(2):237-50. PubMed ID: 6166796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tiapamil in the preexcitation syndrome.
    Gmeiner R; Ng CK; Hochleitner M
    Cardiology; 1982; 69 Suppl():149-56. PubMed ID: 7151077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiology of tiapamil in concealed accessory pathways.
    Gmeiner R; Ng CK
    Cardiology; 1982; 69 Suppl():130-9. PubMed ID: 7151074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the electrophysiologic effects of intravenous and oral verapamil in patients with paroxysmal supraventricular tachycardia.
    Klein GJ; Gulamhusein S; Prystowsky EN; Carruthers SG; Donner AP; Ko PT
    Am J Cardiol; 1982 Jan; 49(1):117-24. PubMed ID: 7053599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Electrophysiological effects and clinical efficacy of flecainide in childhood patients with supraventricular reciprocating paroxysmal tachycardia].
    Musto B; D'Onofrio A; Cavallaro C; Musto A; Della Gatta O; Marsico F
    G Ital Cardiol; 1987 May; 17(5):444-9. PubMed ID: 3115857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concealed accessory pathway and dual AV conduction: drug-dependent reentrant tachycardia.
    Gmeiner R; Ng CK; Gstöttner M
    Clin Cardiol; 1979 Aug; 2(4):291-6. PubMed ID: 262579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia.
    Gambhir DS; Bhargava M; Arora R; Khalilullah M
    Indian Heart J; 1995; 47(3):237-43. PubMed ID: 7558090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect on paroxysmal re-entrant supraventricular tachycardia of a drug affecting calcium transport (Ro 11-1781).
    Gmeiner R; Ng CK; Gstöttner M
    Eur J Clin Pharmacol; 1979 Sep; 16(3):155-64. PubMed ID: 499315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tiapamil on perioperative cardiac arrhythmias and myocardial function.
    List WF; Metzler H
    Cardiology; 1982; 69 Suppl():157-64. PubMed ID: 6185222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiologic effects of diltiazem hydrochloride on supraventricular tachycardia.
    Rozanski JJ; Zaman L; Castellanos A
    Am J Cardiol; 1982 Feb; 49(3):621-8. PubMed ID: 7058770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of cardiac arrhythmias with tiapamil.
    Brisse B; Bender F; Bramann H; Kuhs H; Schwippe G
    Cardiology; 1982; 69 Suppl():144-8. PubMed ID: 7151076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical effectiveness of ethacizine in the treatment of supraventricular paroxysmal tachycardia].
    Lukoshiavichiute AI; Gedrimene DA
    Ter Arkh; 1988; 60(8):41-6. PubMed ID: 3067411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parenteral tiapamil treatment of arrhythmias in cardiac patients.
    Menzel T; Kirchner P
    Cardiology; 1982; 69 Suppl():192-8. PubMed ID: 6185224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [His bundle block 2:1 during paroxysmal supraventricular tachycardia involving an occult accessory atrio-His pathway].
    Finzi A; Potenza S; Guenzati G
    G Ital Cardiol; 1990 Dec; 20(12):1161-7. PubMed ID: 2128068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intravenous diltiazem administration in patients with inducible tachycardia.
    Waleffe A; Hastir F; Kulbertus HE
    Eur Heart J; 1985 Oct; 6(10):882-90. PubMed ID: 4076199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Electrophysiologic effects and clinical efficacy of propafenone in pediatric patients with paroxysmal supraventricular reentrant tachycardia].
    Musto B; D'Onofrio A; Musto A; Cavallaro C; Marsico F
    G Ital Cardiol; 1986 Apr; 16(4):336-43. PubMed ID: 3743937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intravenous diltiazem in the reversion to sinus rhythm in supraventricular tachyarrhythmias].
    Luciardi H; Berman S; Santana M; Monteros L
    Arch Inst Cardiol Mex; 1996; 66(6):505-9. PubMed ID: 9133311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
    Gambhir DS; Bhargava M; Nair M; Arora R; Khalilullah M
    Indian Heart J; 1996; 48(2):133-7. PubMed ID: 8682552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias.
    Boudonas G; Lefkos N; Efthymiadis AP; Styliadis IG; Tsapas G
    Acta Cardiol; 1995; 50(2):125-34. PubMed ID: 7610735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.